Get started
Author

Liat Hayardeny

Observed names: Hayardeny, Liat, L. Hayardeny
OpenAlex ID: A5073432359
Aramchol in patients with nonalcoholic steatohepatitis: a randomized, double-blind, placebo-controlled phase 2b trial
2021 · V. Ratziu, L. de Guevara, et al. · Nature Medicine · 239
Reduced astrocytic NF-κB activation by laquinimod protects from cuprizone-induced demyelination
2012 · Wolfgang Brück, Ramona Pförtner, et al. · Acta Neuropathologica · 170
PDF
Modulation of Autoimmune Demyelination by Laquinimod via Induction of Brain-Derived Neurotrophic Factor
2011 · Jan Thöne, Gisa Ellrichmann, et al. · American Journal Of Pathology · 133
PDF
Laquinimod interferes with migratory capacity of T cells and reduces IL-17 levels, inflammatory demyelination and acute axonal damage in mice with experimental autoimmune encephalomyelitis
2010 · Christiane Wegner, Christine Stadelmann, et al. · Journal of Neuroimmunology · 121
Role of aramchol in steatohepatitis and fibrosis in mice
2017 · Marta Iruarrizaga‐Lejarreta, Marta Varela‐Rey, et al. · Hepatology Communications · 115
PDF
Laquinimod reduces neuroaxonal injury through inhibiting microglial activation
2014 · Manoj Kumar Mishra, Janet Wang, et al. · Annals of Clinical and Translational Neurology · 94
PDF
Aramchol downregulates stearoyl CoA-desaturase 1 in hepatic stellate cells to attenuate cellular fibrogenesis
2021 · Dipankar Bhattacharya, Brittany Basta, et al. · JHEP Reports · 79
PDF
Pharmacogenetics of glatiramer acetate therapy for multiple sclerosis reveals drug-response markers
2007 · Iris Grossman, Nili Avidan, et al. · Pharmacogenetics and Genomics · 74
Oral treatment with laquinimod augments regulatory T-cells and brain-derived neurotrophic factor expression and reduces injury in the CNS of mice with experimental autoimmune encephalomyelitis
2012 · Rina Aharoni, Ravit Saada, et al. · Journal of Neuroimmunology · 71
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles
2022 · Ibon Martínez‐Arranz, Chiara Bruzzone, et al. · Hepatology · 70
PDF
Laquinimod rescues striatal, cortical and white matter pathology and results in modest behavioural improvements in the YAC128 model of Huntington disease
2016 · Marta Garcia-Miralles, Xin Hong, et al. · Scientific Reports · 67
PDF
Laquinimod modulates B cells and their regulatory effects on T cells in Multiple Sclerosis
2012 · Elias Toubi, Shahar Nussbaum, et al. · Journal of Neuroimmunology · 57
Therapeutic laquinimod treatment decreases inflammation, initiates axon remyelination, and improves motor deficit in a mouse model of multiple sclerosis
2013 · Spencer Moore, Anna J. Khalaj, et al. · Brain and Behavior · 53
PDF
Laquinimod treatment in the R6/2 mouse model
2017 · Gisa Ellrichmann, Alina Blusch, et al. · Scientific Reports · 51
Laquinimod prevents inflammation-induced synaptic alterations occurring in experimental autoimmune encephalomyelitis
2012 · Francesca Ruffini, Silvia Rossi, et al. · Multiple Sclerosis Journal · 48
Arachidyl amido cholanoic acid improves liver glucose and lipid homeostasis in nonalcoholic steatohepatitis via AMPK and mTOR regulation
2020 · David Fernández-Ramos, Fernando Lopitz-Otsoa, et al. · World Journal of Gastroenterology · 39
PDF
Laquinimod dampens hyperactive cytokine production in Huntington's disease patient myeloid cells
2016 · Lucianne Dobson, Ulrike Träger, et al. · Journal of Neurochemistry · 39
PDF
Immune surveillance of the central nervous system in multiple sclerosis — Relevance for therapy and experimental models
2014 · Rehana Z. Hussain, Liat Hayardeny, et al. · Journal of Neuroimmunology · 36
PDF
Pharmacogenomics strategies to optimize treatments for multiple sclerosis: Insights from clinical research
2016 · Iris Grossman, Volker Knappertz, et al. · Progress in Neurobiology · 33
Glatiramer acetate-reactive T lymphocytes regulate oligodendrocyte progenitor cell number in vitro: Role of IGF-2
2010 · Y. Zhang, F. Jalili, et al. · Journal of Neuroimmunology · 29
Glatiramer Acetate Protects Against Inflammatory Synaptopathy in Experimental Autoimmune Encephalomyelitis
2013 · Antonietta Gentile, Silvia Rossi, et al. · Journal of Neuroimmune Pharmacology · 24
Laquinimod enhances central nervous system barrier functions
2017 · Fred Lühder, Hania Kebir, et al. · Neurobiology of Disease · 23
Laquinimod prevents cuprizone-induced demyelination independent of Toll-like receptor signaling
2016 · Nadine Kramann, Lena Menken, et al. · Neurology Neuroimmunology & Neuroinflammation · 23
PDF
A New Targeted Model of Experimental Autoimmune Encephalomyelitis in the Common Marmoset
2015 · Ruth Martha Stassart, Gunther Helms, et al. · Brain Pathology · 23
PDF
Safety and in vivo immune assessment of escalating doses of oral laquinimod in patients with RRMS
2017 · Tjalf Ziemssen, Hayrettin Tumani, et al. · Journal of Neuroinflammation · 19
PDF
Works count: 66
Citation count: 1,852
H-index: 23
I10-index: 30
Year
Topic
Type